GILEAD SCIENCES INC (1GILD.MI) Fundamental Analysis & Valuation

BIT:1GILD • US3755581036

126.1 EUR
-2.22 (-1.73%)
Last: Mar 3, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This 1GILD.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to 1GILD. 1GILD was compared to 83 industry peers in the Biotechnology industry. While 1GILD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1GILD has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. 1GILD.MI Profitability Analysis

1.1 Basic Checks

  • 1GILD had positive earnings in the past year.
  • In the past year 1GILD had a positive cash flow from operations.
  • Of the past 5 years 1GILD 4 years were profitable.
  • Of the past 5 years 1GILD 4 years had a positive operating cash flow.
1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCF1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

  • 1GILD's Return On Assets of 13.86% is amongst the best of the industry. 1GILD outperforms 89.16% of its industry peers.
  • With an excellent Return On Equity value of 37.80%, 1GILD belongs to the best of the industry, outperforming 95.18% of the companies in the same industry.
  • The Return On Invested Capital of 1GILD (18.54%) is better than 96.39% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 1GILD is above the industry average of 12.16%.
  • The 3 year average ROIC (16.22%) for 1GILD is below the current ROIC(18.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROIC 18.54%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
1GILD.MI Yearly ROA, ROE, ROIC1GILD.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • 1GILD's Profit Margin of 27.88% is amongst the best of the industry. 1GILD outperforms 83.13% of its industry peers.
  • In the last couple of years the Profit Margin of 1GILD has declined.
  • The Operating Margin of 1GILD (38.96%) is better than 90.36% of its industry peers.
  • In the last couple of years the Operating Margin of 1GILD has grown nicely.
  • 1GILD's Gross Margin of 78.72% is fine compared to the rest of the industry. 1GILD outperforms 65.06% of its industry peers.
  • In the last couple of years the Gross Margin of 1GILD has remained more or less at the same level.
Industry RankSector Rank
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
1GILD.MI Yearly Profit, Operating, Gross Margins1GILD.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. 1GILD.MI Health Analysis

2.1 Basic Checks

  • 1GILD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • There is no outstanding debt for 1GILD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1GILD.MI Yearly Shares Outstanding1GILD.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1GILD.MI Yearly Total Debt VS Total Assets1GILD.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • There is no outstanding debt for 1GILD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC2.22
WACC8.34%
1GILD.MI Yearly LT Debt VS Equity VS FCF1GILD.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

  • 1GILD has a Current Ratio of 1.53. This is a normal value and indicates that 1GILD is financially healthy and should not expect problems in meeting its short term obligations.
  • 1GILD has a Current ratio of 1.53. This is in the lower half of the industry: 1GILD underperforms 60.24% of its industry peers.
  • A Quick Ratio of 1.17 indicates that 1GILD should not have too much problems paying its short term obligations.
  • 1GILD has a worse Quick ratio (1.17) than 62.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.17
1GILD.MI Yearly Current Assets VS Current Liabilites1GILD.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 1GILD.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.79% over the past year.
  • 1GILD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.83% yearly.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.7%

3.2 Future

  • 1GILD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.47% yearly.
  • Based on estimates for the next years, 1GILD will show a small growth in Revenue. The Revenue will grow by 4.32% on average per year.
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue Next Year3.45%
Revenue Next 2Y4.28%
Revenue Next 3Y4.12%
Revenue Next 5Y4.32%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
1GILD.MI Yearly Revenue VS Estimates1GILD.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
1GILD.MI Yearly EPS VS Estimates1GILD.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. 1GILD.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 17.89, the valuation of 1GILD can be described as rather expensive.
  • 1GILD's Price/Earnings ratio is rather cheap when compared to the industry. 1GILD is cheaper than 83.13% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.29, 1GILD is valued a bit cheaper.
  • 1GILD is valuated correctly with a Price/Forward Earnings ratio of 16.34.
  • 1GILD's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1GILD is cheaper than 90.36% of the companies in the same industry.
  • 1GILD's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.60.
Industry RankSector Rank
PE 17.89
Fwd PE 16.34
1GILD.MI Price Earnings VS Forward Price Earnings1GILD.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1GILD is valued cheaper than 83.13% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, 1GILD is valued cheaply inside the industry as 89.16% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19
EV/EBITDA 12.16
1GILD.MI Per share data1GILD.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • 1GILD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.89
PEG (5Y)6.33
EPS Next 2Y8.64%
EPS Next 3Y8.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. 1GILD.MI Dividend Analysis

5.1 Amount

  • 1GILD has a Yearly Dividend Yield of 2.16%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.66, 1GILD pays a better dividend. On top of this 1GILD pays more dividend than 91.57% of the companies listed in the same industry.
  • 1GILD's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.16%

5.2 History

  • The dividend of 1GILD has a limited annual growth rate of 4.45%.
Dividend Growth(5Y)4.45%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 1GILD pays out 12.00% of its income as dividend. This is a sustainable payout ratio.
  • 1GILD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP12%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
1GILD.MI Yearly Income VS Free CF VS Dividend1GILD.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
1GILD.MI Dividend Payout.1GILD.MI Dividend Payout, showing the Payout Ratio.1GILD.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1GILD.MI Fundamentals: All Metrics, Ratios and Statistics

GILEAD SCIENCES INC

BIT:1GILD (3/3/2026, 7:00:00 PM)

126.1

-2.22 (-1.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10
Earnings (Next)04-22
Inst Owners91.58%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap156.45B
Revenue(TTM)N/A
Net Income(TTM)8.11B
Analysts81.62
Price Target118.53 (-6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.16%
Yearly Dividend2.65
Dividend Growth(5Y)4.45%
DP12%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)0%
PT rev (3m)5.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.52%
EPS NY rev (1m)0%
EPS NY rev (3m)1.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.33%
Valuation
Industry RankSector Rank
PE 17.89
Fwd PE 16.34
P/S 6.22
P/FCF 19
P/OCF 18.71
P/B 8.43
P/tB N/A
EV/EBITDA 12.16
EPS(TTM)7.05
EY5.59%
EPS(NY)7.72
Fwd EY6.12%
FCF(TTM)6.64
FCFY5.26%
OCF(TTM)6.74
OCFY5.34%
SpS20.28
BVpS14.96
TBVpS-3.37
PEG (NY)1.89
PEG (5Y)6.33
Graham Number48.71
Profitability
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROCE 24.51%
ROIC 18.54%
ROICexc 23.24%
ROICexgc 80.87%
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
FCFM 32.73%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
ROICexc(3y)19.38%
ROICexc(5y)17.72%
ROICexgc(3y)93.83%
ROICexgc(5y)93.24%
ROCE(3y)21.45%
ROCE(5y)19.94%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y15.06%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.39%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 68.56%
Profit Quality 117.39%
Current Ratio 1.53
Quick Ratio 1.17
Altman-Z N/A
F-Score7
WACC8.34%
ROIC/WACC2.22
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.7%
Revenue Next Year3.45%
Revenue Next 2Y4.28%
Revenue Next 3Y4.12%
Revenue Next 5Y4.32%
EBIT growth 1Y4.49%
EBIT growth 3Y2.36%
EBIT growth 5Y12.88%
EBIT Next Year76.07%
EBIT Next 3Y25.58%
EBIT Next 5Y19.26%
FCF growth 1Y21.23%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y15.03%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%

GILEAD SCIENCES INC / 1GILD.MI FAQ

What is the ChartMill fundamental rating of GILEAD SCIENCES INC (1GILD.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1GILD.MI.


What is the valuation status for 1GILD stock?

ChartMill assigns a valuation rating of 6 / 10 to GILEAD SCIENCES INC (1GILD.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for GILEAD SCIENCES INC?

GILEAD SCIENCES INC (1GILD.MI) has a profitability rating of 8 / 10.


What are the PE and PB ratios of GILEAD SCIENCES INC (1GILD.MI) stock?

The Price/Earnings (PE) ratio for GILEAD SCIENCES INC (1GILD.MI) is 17.89 and the Price/Book (PB) ratio is 8.43.


What is the financial health of GILEAD SCIENCES INC (1GILD.MI) stock?

The financial health rating of GILEAD SCIENCES INC (1GILD.MI) is 5 / 10.